Home 
Bratislava Medical Journal Ahead of print Bratislava Medical Journal Vol.124, No.6, p.449–453, 2023
Bratislava Medical Journal Ahead of print Bratislava Medical Journal Vol.124, No.6, p.449–453, 2023
Journal info
|
||||
Select Journal
Journals
Bratislava Medical Journal 2024 Ahead of print 2023 2022 2021 2020 2019 2018 2017 2016 2015 2014 2013 2012 Endocrine Regulations General Physiology and Biophysics Neoplasma Acta Virologica Studia Psychologica Cardiology Letters Psychológia a patopsych. dieťaťa Kovove Materialy-Metallic Materials Slovenská hudbaWebshop Cart
Your Cart is currently empty.
Info: Your browser does not accept cookies. To put products into your cart and purchase them you need to enable cookies.
Bratislava Medical Journal Vol.124, No.6, p.449–453, 2023 |
||
| Title: Serum vitamin D levels and inflammatory status in COVID-19 patients | ||
| Author: Desislava ARABADZHIYSKA, Tanya DENEVA | ||
| Abstract: OBJECTIVES: The coronavirus 2019 disease (COVID-19) is characterized by a heterogeneous clinical presentation, a complex pathophysiology and a wide range of laboratory findings, depending on disease severity. BACKGROUND: We studied some laboratory parameters in correlation with vitamin D status representing the inflammatory state in hospitalized COVID-19 patients on admission. METHODS: The study included 100 COVID-19 patients with moderate (n=55) and severe (n=45) form of the disease. Complete blood count and differential blood count, routine biochemical parameters, C-reactive protein and serum procalcitonin, ferritin, human IL-6 and serum vitamin D (measured as 25-OH vitamin D) concentrations, were performed. RESULTS: According to the severity of the disease, patients with severe form had significantly lower serum vitamin D (16.54±6.51 ng/ml vs 20.37±5.63 ng/ml, p=0.0012), higher serum interleukin-6 (41.24±28.46 pg/ml vs. 24.75±16.28 pg/ml, p=0.0003), C-reactive protein (101.49± 57.15 mg/l vs 74.43±42.99 mg/l, p=0.0044), ferritin (969.89±338.37 ng/ml vs 845.96±359.91 ng/ml, p=0.0423) and LDH (1050.53±369.11 U/l vs 905.31±335.57 U/l, p=0.0222) compared to those with moderate form of the disease. CONCLUSION: The presented data provide a relationship between increased inflammatory laboratory markers, low vitamin D levels and disease severity in COVID-19 patients (Tab. 2, Fig. 3, Ref. 32). |
||
| Keywords: COVID-19, 25-OH vitamin D, IL-6, C-reactive protein | ||
| Published online: 28-Feb-2023 | ||
| Year: 2023, Volume: 124, Issue: 6 | Page From: 449, Page To: 453 | |
| doi:10.4149/BLL_2023_069 |
||
|
|
 download file |
|